Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Ciprofloxacin

Research Leaders

6 sponsors active, led by Nanfang Hospital, Southern Medical University

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 4 (1)

Trial Status

Completed2
Unknown1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (4)

Showing 4 of 4 trials
NCT07579104CompletedPrimary

Pyogenic Liver Abcess in Guadeloupe

NCT07303829Not ApplicableNot Yet RecruitingPrimary

Laparoscopic Approach to Pyogenic Liver Abscess

NCT05213949UnknownPrimary

An Observational Study of Risk Factors and Long-term Prognosis of Patients With Liver Abscess in the "Real-world"

NCT01723150Phase 4CompletedPrimary

Antibiotics for Klebsiella Liver Abscess Study

Showing all 4 trials

Research Network

Common Treatments

  • Ciprofloxacin1
  • Ceftriaxone1
  • Ertapenem1
  • Laproscopic1
  • Trimethoprimsulfamethoxazole1

Active Sponsors

  • Nanfang Hospital, Southern Medical University1
  • Singapore General Hospital1
  • Tan Tock Seng Hospital1
  • National University Hospital, Singapore1
  • Centre Hospitalier Universitaire de la Guadeloupe1

Top Investigators

Related Conditions

  • Liver Abscess1
  • Infections1
  • Abscess1

Activity Timeline